Porphycene compounds for photodynamic therapy

Details Porphycene compounds for photodynamic therapy Porphycene compounds for photodynamic therapy

1993-08-06

1995-04-25

Shah, Mukund J.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514410, 514 2, 514 18, 540472, 530329, 530330, 530331, 530345, A61K 3140, C07D48722

Patent

active

054099005

ABSTRACT:
A porphycene having the structure ##STR1## wherein each R.sup.1 is, independently, (a) --(CH.sub.2).sub.n --X, where n=1-4, X is OR.sup.2 and R.sup.2 is C.sub.1-6 alkyl, aralkyl or aryl; CN; OH; OSO.sub.2 R.sup.2 ; NH.sub.2 ; NHR.sup.2 ; NR.sub.2.sup.2 ; SH; SR.sup.2 ; S(O).sub.1-2 R.sup.2 ; COOH; CO.sub.2 R.sup.2 ; C(O)NH.sub.2 ; C(O)NHR.sup.2 ; C(O)NR.sub.2.sup.2 ; halogen; or CHO;

REFERENCES:
patent: 5015478 (1991-05-01), Jori et al.
patent: 5132101 (1992-07-01), Vogel et al.
patent: 5179120 (1993-01-01), Vogel et al.
patent: 5262401 (1993-11-01), Vogel et al.

Affiliated with

Also associated with

Rating

Porphycene compounds for photodynamic therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Porphycene compounds for photodynamic therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Porphycene compounds for photodynamic therapy will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1567714